Anti-TNF to prevent and treat postoperative recurrence of Crohn's disease

Premium Content

Please purchase any of the premium collections shown to access this library item.

View all of your premium content purchases in myUEG > My Learning.
If you need help or have questions, please contact

This item was part of the Therapy update: Best use of biologics in IBD in 2014 session at UEG Week 2014

You may be interested in:

Therapeutic objectives: Clinical features and biomarkers
English, Presentation, Endoscopy, IBD, Radiology & Imaging, 2017
Amgen - The emerging treatment landscape of IBD: role of innovator biologics and biosimilars (Amgen Europe GmbH)
English, Presentation, Industry Sponsored Symposia, Industry Sponsored Symposia, 2018, Amgen Europe GmbH


  • Format
    • Presentation
  • UEG Week Pathway
    • Intestinal & Motility
  • Year
    • 2014